Literature DB >> 19839747

Bordetella pertussis and pertussis vaccines.

Nicole Guiso1.   

Abstract

Bordetella pertussis is a human-specific pathogen that causes whooping cough. The use of pertussis whole-cell vaccines in infants and toddlers led to decreased circulation of the bacterium in the child population and a marked decrease in the incidence of the disease. However, vaccine does not result in life-long immunity; indeed, the circulation of the bacterium has not been controlled in the adult population. Universal adult booster immunization is now possible using pertussis acellular vaccines, which target-and are thus likely to control-the virulence of this bacterium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19839747     DOI: 10.1086/644733

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

1.  How to fight pertussis?

Authors:  Nicole Guiso
Journal:  Ther Adv Vaccines       Date:  2013-07

2.  Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland.

Authors:  Alex-Mikael Barkoff; Jussi Mertsola; Sophie Guillot; Nicole Guiso; Guy Berbers; Qiushui He
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

3.  Serum immunoglobulin G analysis to establish a delayed diagnosis of chronic cough due to Bordetella pertussis.

Authors:  Jonathan M Bock; Charles C Burtis; David M Poetker; Joel H Blumin; Michael O Frank
Journal:  Otolaryngol Head Neck Surg       Date:  2011-10-10       Impact factor: 3.497

4.  The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.

Authors:  Jamie Jennings-Gee; Sally Quataert; Tridib Ganguly; Ralph D'Agostino; Rajendar Deora; Purnima Dubey
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

5.  Comparison of rates of positivity for Bordetella pertussis by real-time PCR between specimens collected with rayon swabs on aluminum wire shaft in Amies gel with charcoal and specimens collected with flocked swabs in universal viral transport medium during an epidemic.

Authors:  Sophie Arbefeville; Patricia Ferrieri
Journal:  J Clin Microbiol       Date:  2014-04-30       Impact factor: 5.948

6.  Bis-halogen-anthraniloyl-substituted nucleoside 5'-triphosphates as potent and selective inhibitors of Bordetella pertussis adenylyl cyclase toxin.

Authors:  Jens Geduhn; Stefan Dove; Yuequan Shen; Wei-Jen Tang; Burkhard König; Roland Seifert
Journal:  J Pharmacol Exp Ther       Date:  2010-10-20       Impact factor: 4.030

7.  Core pertussis transmission groups in England and Wales: A tale of two eras.

Authors:  Ana I Bento; Maria A Riolo; Yoon H Choi; Aaron A King; Pejman Rohani
Journal:  Vaccine       Date:  2018-02-01       Impact factor: 3.641

8.  Immunoproteomic analysis of human serological antibody responses to vaccination with whole-cell pertussis vaccine (WCV).

Authors:  Yong-Zhang Zhu; Cheng-Song Cai; Wei Zhang; Hong-Xiong Guo; Jin-Ping Zhang; Ya-Yong Ji; Guang-Yuan Ma; Jia-Lin Wu; Qing-Tian Li; Cheng-Ping Lu; Xiao-Kui Guo
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

Review 9.  Development of vaccines for Candida albicans: fighting a skilled transformer.

Authors:  Antonio Cassone
Journal:  Nat Rev Microbiol       Date:  2013-12       Impact factor: 60.633

Review 10.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.